Scheme 3 Alternative route to porphyrin 9.
(8.45)%. FAB-MS: m/z = 1393,8 [M Ϫ NO3]ϩ. UV-VIS
References
(CH2Cl2, λ/nm, 10Ϫ3ε/MϪ1 cmϪ1): 354 (42.4), 472 (176.9), 598
(9.8), 644 (8.3). FTIR (KBr, cmϪ1): 1732 (CO)ester, 1695
(CO)amide, 1384 (NO3), 991 (Bi–N(por)). 1H NMR (CDCl3, 300
K, 500 MHz): δ 9.24 (8H, s, β-pyr), 8.68 (4H, br s, arom), 8.22
(3H, br s, –NHCO), 8.13 (1H, br s, –NHCO), 7.89 (4H, m,
arom), 7.90 (4H, t, arom), 7.56 (4H, br s, arom), 3.46 (2H,
br s, –CH2CH3), 3.32 (6H, br s, –CH2CH3), 2.04 (8H, br s,
–CH2CH2), 1.92 (8H, br s, –CH2CH2), 0.96 (3H, br s,
–CH2CH3), 0.87 (9H, s, –CH2CH3). 13C NMR (CDCl3, 300 K,
125 MHz): δC 173.5, 170.8, 149.3, 140.4, 134.9, 133.5, 131.3,
130.6, 123.6, 123.1, 122.7, 119.3, 60.8, 31.5, 29.5, 14.1.
1 G. Baxter, Chem. Ber., 1992, 28, 445.
2 R. Kozak, T. Waldmann, R. Atcher and O. Gansow, Trends
Biotechnol., 1985, 4, 259; D. E. Milenic, M. Roselli, S. Mirzadeh,
C. G. Pippin, O. A. Gansow, D. Colcher, M. W. Brechbiel and
J. Schlom, Cancer Biother. Radiopharm., 2001, 16, 133.
3 S. Hassfjell and M. W. Brechbiel, Chem. Rev., 2001, 101, 2019.
4 R. Hancock, I. Cukrowski, J. Baloyi and J. Mashishi, J. Chem. Soc.,
Dalton Trans., 1993, 2895; R. Luckay, J. Reibenspie and
R. Hancock, J. Chem. Soc., Chem. Commun., 1995, 2365; R. Luckay,
I. Cukrowski, J. Mashishi, J. Reibenspies, A. Bond, R. Rogers and
R. Hancock, J. Chem. Soc., Dalton Trans., 1997, 901.
5 M. W. Brechbiel, C. G. Pippin, T. J. McMurry, D. Milenic,
D. Roselli, D. Colcher and O. A. Gansow, J. Chem. Soc., Chem.
Commun., 1991, 1169; T. K. Nikula, M. R. McDevitt, R. D. Finn,
C. Wu, K. R. W. K. Garmestani, M. W. Brechbiel, M. J. Curcio,
C. G. Pippin, L. Tiffany-Jones, M. W. Geerlings, C. Apostolidis,
R. Molinet, M. W. Geerlings, O. A. Gansow and D. A. Scheinberg,
J. Nucl. Med., 1999, 40, 166.
Crystallography for 1BiNO3
Crystallographic details for 1BiNO3 have already been reported
in ref. 9. Crystal data: C68H64BiN9O15ؒ2H2O, M = 1492.3, tri-
¯
clinic, space group P1, a = 14.3980(4), b = 14.9790(4), c =
6 A. Treibs, Justus Liebigs Ann. Chem., 1969, 728, 115; J. W. Buchler
and K. L. Lay, Inorg. Nucl. Chem. Lett., 1974, 10, 297.
7 J. Barbour, W. J. Belcher, P. J. Brothers, C. E. F. Rickard and
D. C. Ware, Inorg. Chem., 1992, 31, 746; B. Boitrel, M. Breede,
P. J. Brothers, M. Hodgson, L. Michaudet, C. E. F. Rickard and
N. Al Salim, Dalton Trans., 2003, 1803.
8 L. Michaudet, D. Fasseur, R. Guilard, Z. Ou, K. M. Kadish,
S. Dahoui and C. Lecomte, J. Porphyrins Phtalocyanines, 2000, 4,
261.
9 L. Michaudet, P. Richard and B. Boitrel, Chem. Commun., 2000,
1589.
10 D. A. Buckingham, C. R. Clark and W. S. Webley, J. Chem. Soc.,
Chem. Commun., 1981, 192.
16.5670(4) Å, α = 116.205(1), β = 97.2490(11), γ = 92.6720(12)Њ,
V = 3159.02(14) Å3, Z = 2, Dc = 1.569 g cmϪ3, F(000) = 1516.
Data were collected at 110 K on a Nonius Kappa CCD dif-
fractometer with Mo-Kα radiation (λ = 0.71073 Å). The struc-
ture was solved by a Patterson search program and refined by
full-matrix least-squares method on F 2 (14332 unique reflec-
tions, 1054 parameters). The anisotropic refinement led to final
residuals wR2 = 0.101 for all data and R1 = 0.055 for 10533
intensities with I > 2σ(I ), and GOF = 1.028. The largest ∆(ρ)
residual densities are 1.36 and Ϫ1.69 e ÅϪ3
.
CCDC reference number 149483.
lographic data in CIF or other electronic format.
11 L. J. Farrugia, J. Appl. Crystallogr., 1997, 30, 565.
12 R. D. Shannon, Acta Crystallogr., Sect. A, 1976, 32, 751.
13 D. J. Nurco, C. J. Medforth, T. P. Forsyth, M. M. Olmstead and
K. M. Smith, J. Am. Chem. Soc., 1996, 118, 10918.
14 P. Permutter, M. Rose and P. Shenan, Tetrahedron Lett., 1988, 29,
1427; B. Boitrel, E. Camilleri, Y. Fleche, A. Lecas and E. Rose,
Tetrahedron Lett., 1989, 30, 2923.
15 B. Boitrel, A. Lecas and E. Rose, J. Chem. Soc., Chem. Commun.,
1989, 349.
Acknowledgements
The CNRS, La Ligue contre le cancer as well as Région
Bretagne are gratefully acknowledged for financial support.
D a l t o n T r a n s . , 2 0 0 3 , 4 2 5 0 – 4 2 5 4
4254